NervGen Pharma Corp. (NGEN)
1.78
+0.02
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
NervGen Pharma Cash from Operations (TTM) : -18.43M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.43M |
| March 31, 2026 | -17.09M |
| December 31, 2025 | -13.98M |
| September 30, 2025 | -11.89M |
| June 30, 2025 | -12.23M |
| March 31, 2025 | -12.51M |
| December 31, 2024 | -12.04M |
| September 30, 2024 | -11.84M |
| June 30, 2024 | -8.677M |
| March 31, 2024 | -7.167M |
| December 31, 2023 | -8.294M |
| September 30, 2023 | -9.472M |
| June 30, 2023 | -11.94M |
| March 31, 2023 | -13.29M |
| December 31, 2022 | -13.10M |
| Date | Value |
|---|---|
| September 30, 2022 | -12.01M |
| June 30, 2022 | -10.00M |
| March 31, 2022 | -8.881M |
| December 31, 2021 | -6.560M |
| September 30, 2021 | -5.868M |
| June 30, 2021 | -5.279M |
| March 31, 2021 | -4.439M |
| December 31, 2020 | -4.84M |
| September 30, 2020 | -4.792M |
| June 30, 2020 | -5.508M |
| March 31, 2020 | -5.601M |
| December 31, 2019 | -6.132M |
| September 30, 2019 | -5.130M |
| June 30, 2019 | -3.711M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| InMed Pharmaceuticals, Inc. | -8.628M |
| Milestone Pharmaceuticals, Inc. | -60.75M |
| Clearmind Medicine, Inc. | -6.997M |
| Lexaria Bioscience Corp. | -7.426M |
| Target Group, Inc. (Canada) | -1.073M |